Improvement in survival of patients with oral cavity squamous cell carcinoma: An international collaborative study
BACKGROUND An association between the survival of patients with oral cavity squamous cell carcinoma (OCSCC) and advancements in diagnosis and therapy has not been established. METHODS This was a retrospective, longitudinal, international, population‐based study of 2738 patients who underwent resecti...
Saved in:
Published in | Cancer Vol. 119; no. 24; pp. 4242 - 4248 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken, NJ
Wiley-Blackwell
15.12.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | BACKGROUND
An association between the survival of patients with oral cavity squamous cell carcinoma (OCSCC) and advancements in diagnosis and therapy has not been established.
METHODS
This was a retrospective, longitudinal, international, population‐based study of 2738 patients who underwent resection of OCSCC during 2 different decades. Characteristics of patients from 7 international cancer centers who received treatment between 1990 and 2000 (group A; n = 735) were compared with patients who received treatment between 2001 and 2011 (group B; n = 2003).
RESULTS
Patients in group B had more advanced tumors and tended to develop distant metastases more frequently than patients in group A (P = .005). More group B patients underwent selective neck dissection and received adjuvant radiotherapy (P < .001). Outcome analysis revealed a significant improvement in 5‐year overall survival, from 59% for group A to 70% for group B (P < .001). There was also a significant improvement in disease‐specific survival associated with operations performed before and after 2000 (from 69% to 81%, respectively; P < .001). Surgery after 2000, negative margins, adjuvant treatment, and early stage disease were independent predictors of a better outcome in multivariate analysis. The decade of treatment was an independent prognostic factor for cancer‐specific mortality (hazard ratio, 0.42; 95% confidence interval, 0.3‐0.6).
CONCLUSIONS
The survival rate of patients with OCSCC improved significantly during the past 2 decades despite older age, more advanced disease stage, and a higher rate of distant metastases. The current results suggest that the prognosis for patients with OCSCC has improved over time, presumably because of advances in imaging and therapy. Cancer 2013;119:4242–4248. © 2013 American Cancer Society.
The survival rate of patients with oral cavity cancer has improved significantly during the past 2 decades despite higher stage disease, and a higher rate of distant metastases. The decade of treatment is identified as an independent prognostic factor for outcome with a hazard ratio of 0.42 for cancer‐specific mortality. |
---|---|
AbstractList | An association between the survival of patients with oral cavity squamous cell carcinoma (OCSCC) and advancements in diagnosis and therapy has not been established.BACKGROUNDAn association between the survival of patients with oral cavity squamous cell carcinoma (OCSCC) and advancements in diagnosis and therapy has not been established.This was a retrospective, longitudinal, international, population-based study of 2738 patients who underwent resection of OCSCC during 2 different decades. Characteristics of patients from 7 international cancer centers who received treatment between 1990 and 2000 (group A; n = 735) were compared with patients who received treatment between 2001 and 2011 (group B; n = 2003).METHODSThis was a retrospective, longitudinal, international, population-based study of 2738 patients who underwent resection of OCSCC during 2 different decades. Characteristics of patients from 7 international cancer centers who received treatment between 1990 and 2000 (group A; n = 735) were compared with patients who received treatment between 2001 and 2011 (group B; n = 2003).Patients in group B had more advanced tumors and tended to develop distant metastases more frequently than patients in group A (P = .005). More group B patients underwent selective neck dissection and received adjuvant radiotherapy (P < .001). Outcome analysis revealed a significant improvement in 5-year overall survival, from 59% for group A to 70% for group B (P < .001). There was also a significant improvement in disease-specific survival associated with operations performed before and after 2000 (from 69% to 81%, respectively; P < .001). Surgery after 2000, negative margins, adjuvant treatment, and early stage disease were independent predictors of a better outcome in multivariate analysis. The decade of treatment was an independent prognostic factor for cancer-specific mortality (hazard ratio, 0.42; 95% confidence interval, 0.3-0.6).RESULTSPatients in group B had more advanced tumors and tended to develop distant metastases more frequently than patients in group A (P = .005). More group B patients underwent selective neck dissection and received adjuvant radiotherapy (P < .001). Outcome analysis revealed a significant improvement in 5-year overall survival, from 59% for group A to 70% for group B (P < .001). There was also a significant improvement in disease-specific survival associated with operations performed before and after 2000 (from 69% to 81%, respectively; P < .001). Surgery after 2000, negative margins, adjuvant treatment, and early stage disease were independent predictors of a better outcome in multivariate analysis. The decade of treatment was an independent prognostic factor for cancer-specific mortality (hazard ratio, 0.42; 95% confidence interval, 0.3-0.6).The survival rate of patients with OCSCC improved significantly during the past 2 decades despite older age, more advanced disease stage, and a higher rate of distant metastases. The current results suggest that the prognosis for patients with OCSCC has improved over time, presumably because of advances in imaging and therapy.CONCLUSIONSThe survival rate of patients with OCSCC improved significantly during the past 2 decades despite older age, more advanced disease stage, and a higher rate of distant metastases. The current results suggest that the prognosis for patients with OCSCC has improved over time, presumably because of advances in imaging and therapy. An association between the survival of patients with oral cavity squamous cell carcinoma (OCSCC) and advancements in diagnosis and therapy has not been established. This was a retrospective, longitudinal, international, population-based study of 2738 patients who underwent resection of OCSCC during 2 different decades. Characteristics of patients from 7 international cancer centers who received treatment between 1990 and 2000 (group A; n = 735) were compared with patients who received treatment between 2001 and 2011 (group B; n = 2003). Patients in group B had more advanced tumors and tended to develop distant metastases more frequently than patients in group A (P = .005). More group B patients underwent selective neck dissection and received adjuvant radiotherapy (P < .001). Outcome analysis revealed a significant improvement in 5-year overall survival, from 59% for group A to 70% for group B (P < .001). There was also a significant improvement in disease-specific survival associated with operations performed before and after 2000 (from 69% to 81%, respectively; P < .001). Surgery after 2000, negative margins, adjuvant treatment, and early stage disease were independent predictors of a better outcome in multivariate analysis. The decade of treatment was an independent prognostic factor for cancer-specific mortality (hazard ratio, 0.42; 95% confidence interval, 0.3-0.6). The survival rate of patients with OCSCC improved significantly during the past 2 decades despite older age, more advanced disease stage, and a higher rate of distant metastases. The current results suggest that the prognosis for patients with OCSCC has improved over time, presumably because of advances in imaging and therapy. The survival rate of patients with oral cavity cancer has improved significantly during the past 2 decades despite higher stage disease, and a higher rate of distant metastases. The decade of treatment is identified as an independent prognostic factor for outcome with a hazard ratio of 0.42 for cancer‐specific mortality. BACKGROUND An association between the survival of patients with oral cavity squamous cell carcinoma (OCSCC) and advancements in diagnosis and therapy has not been established. METHODS This was a retrospective, longitudinal, international, population‐based study of 2738 patients who underwent resection of OCSCC during 2 different decades. Characteristics of patients from 7 international cancer centers who received treatment between 1990 and 2000 (group A; n = 735) were compared with patients who received treatment between 2001 and 2011 (group B; n = 2003). RESULTS Patients in group B had more advanced tumors and tended to develop distant metastases more frequently than patients in group A (P = .005). More group B patients underwent selective neck dissection and received adjuvant radiotherapy (P < .001). Outcome analysis revealed a significant improvement in 5‐year overall survival, from 59% for group A to 70% for group B (P < .001). There was also a significant improvement in disease‐specific survival associated with operations performed before and after 2000 (from 69% to 81%, respectively; P < .001). Surgery after 2000, negative margins, adjuvant treatment, and early stage disease were independent predictors of a better outcome in multivariate analysis. The decade of treatment was an independent prognostic factor for cancer‐specific mortality (hazard ratio, 0.42; 95% confidence interval, 0.3‐0.6). CONCLUSIONS The survival rate of patients with OCSCC improved significantly during the past 2 decades despite older age, more advanced disease stage, and a higher rate of distant metastases. The current results suggest that the prognosis for patients with OCSCC has improved over time, presumably because of advances in imaging and therapy. Cancer 2013;119:4242–4248. © 2013 American Cancer Society. The survival rate of patients with oral cavity cancer has improved significantly during the past 2 decades despite higher stage disease, and a higher rate of distant metastases. The decade of treatment is identified as an independent prognostic factor for outcome with a hazard ratio of 0.42 for cancer‐specific mortality. |
Author | Kreppel, Matthias Gil, Ziv Kowalski, Luiz P. Ebrahimi, Ardalan Shah, Jatin P. Zöller, Joachim Fridman, Eran Binenbaum, Yoav Agarwal, Jai Prakash Chaturvedi, Pankaj Yen, Tzu‐Chen Amit, Moran Bolzoni, Villaret A. Clark, Jonathan R. Liao, Chun‐Ta Patel, Snehal G. |
Author_xml | – sequence: 1 givenname: Moran surname: Amit fullname: Amit, Moran organization: Israel Institute of Technology – sequence: 2 givenname: Tzu‐Chen surname: Yen fullname: Yen, Tzu‐Chen organization: Chang Gung Memorial Hospital – sequence: 3 givenname: Chun‐Ta surname: Liao fullname: Liao, Chun‐Ta organization: Chang Gung Memorial Hospital – sequence: 4 givenname: Pankaj surname: Chaturvedi fullname: Chaturvedi, Pankaj organization: Tata Memorial Hospital – sequence: 5 givenname: Jai Prakash surname: Agarwal fullname: Agarwal, Jai Prakash organization: Tata Memorial Hospital – sequence: 6 givenname: Luiz P. surname: Kowalski fullname: Kowalski, Luiz P. organization: Hospital AC Camargo – sequence: 7 givenname: Ardalan surname: Ebrahimi fullname: Ebrahimi, Ardalan organization: Royal Prince Alfred Hospital – sequence: 8 givenname: Jonathan R. surname: Clark fullname: Clark, Jonathan R. organization: Royal Prince Alfred Hospital – sequence: 9 givenname: Matthias surname: Kreppel fullname: Kreppel, Matthias organization: University of Cologne – sequence: 10 givenname: Joachim surname: Zöller fullname: Zöller, Joachim organization: University of Cologne – sequence: 11 givenname: Eran surname: Fridman fullname: Fridman, Eran organization: Israel Institute of Technology – sequence: 12 givenname: Villaret A. surname: Bolzoni fullname: Bolzoni, Villaret A. organization: University of Brescia – sequence: 13 givenname: Jatin P. surname: Shah fullname: Shah, Jatin P. organization: Memorial Sloan Kettering Cancer Center – sequence: 14 givenname: Yoav surname: Binenbaum fullname: Binenbaum, Yoav organization: Israel Institute of Technology – sequence: 15 givenname: Snehal G. surname: Patel fullname: Patel, Snehal G. organization: Memorial Sloan Kettering Cancer Center – sequence: 16 givenname: Ziv surname: Gil fullname: Gil, Ziv organization: Israel Institute of Technology |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28032833$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/24114787$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kd1rFDEUxYO02G31xT9A8iIUYWo-m4xvZfGjUCqIgm9DJnuDkZlkm2Sm7H9vprsqlOJTyOF3Dvfec4qOQgyA0CtKLigh7J0NNl0wzaV6hlaUtKohVLAjtCKE6EYK_uMEneb8q34Vk_w5OmGCUqG0WqF0PW5TnGGEULAPOE9p9rMZcHR4a4qvcsb3vvzEMVXVmtmXHc53kxnjlLGFYRGT9SGO5j2-CjWkQArVGsNiiMNg-uotfgacy7TZvUDHzgwZXh7eM_T944dv68_NzZdP1-urm8ZySlRjtOVW6p4BEU5Qwtq25dJtVA-sV8ww6y57zTUwooWwjIMkknPnxMZJaAU_Q-f73Lrg3QS5dKPPy8AmQJ29o-JSUiVbRSv6-oBO_Qibbpv8aNKu-3OnCrw5ACZbM7hkgvX5H6cJrwXwyr3dczbFnBO4vwgl3VJWt5TVPZRVYfIItr48HK4k44enLXRvufcD7P4T3q1v11_3nt-Hmqgz |
CODEN | CANCAR |
CitedBy_id | crossref_primary_10_1038_s41415_019_0523_0 crossref_primary_10_1002_cam4_1216 crossref_primary_10_1097_CEJ_0000000000000932 crossref_primary_10_1111_ans_13512 crossref_primary_10_1002_cncy_22249 crossref_primary_10_1016_j_identj_2024_09_035 crossref_primary_10_1016_j_radonc_2019_01_014 crossref_primary_10_1177_0194599820949223 crossref_primary_10_1002_lary_27315 crossref_primary_10_1038_s41598_024_56694_y crossref_primary_10_1177_1073274820920727 crossref_primary_10_1016_j_radonc_2020_08_013 crossref_primary_10_1111_cas_16028 crossref_primary_10_1002_adbi_202300162 crossref_primary_10_5125_jkaoms_2022_48_5_284 crossref_primary_10_1016_j_oraloncology_2016_12_006 crossref_primary_10_1111_odi_13933 crossref_primary_10_1016_j_clon_2019_05_013 crossref_primary_10_4103_ijc_IJC_445_17 crossref_primary_10_1016_j_oraloncology_2021_105451 crossref_primary_10_1089_cbr_2019_2907 crossref_primary_10_1002_hed_25622 crossref_primary_10_20396_bjos_v22i00_8668473 crossref_primary_10_1007_s12672_025_01998_2 crossref_primary_10_1016_j_oraloncology_2019_02_001 crossref_primary_10_1111_odi_13147 crossref_primary_10_1111_odi_14353 crossref_primary_10_1016_j_ijrobp_2018_09_013 crossref_primary_10_1038_s41379_019_0426_2 crossref_primary_10_1016_j_cps_2016_06_001 crossref_primary_10_1016_j_prp_2021_153474 crossref_primary_10_1002_osi2_1201 crossref_primary_10_1002_hed_24589 crossref_primary_10_1016_j_suronc_2025_102213 crossref_primary_10_1002_hed_24740 crossref_primary_10_1016_j_oraloncology_2015_10_012 crossref_primary_10_1002_hed_26487 crossref_primary_10_1002_hed_24507 crossref_primary_10_5897_JCREO2023_0184 crossref_primary_10_5301_tj_5000425 crossref_primary_10_1016_j_eujim_2020_101162 crossref_primary_10_1002_hed_27748 crossref_primary_10_3892_mco_2017_1276 crossref_primary_10_1007_s00784_018_2424_z crossref_primary_10_1016_j_ijom_2021_05_020 crossref_primary_10_1016_j_compbiolchem_2025_108348 crossref_primary_10_1016_j_oooo_2021_08_021 crossref_primary_10_2147_CMAR_S272498 crossref_primary_10_1002_cncr_31531 crossref_primary_10_1002_hed_24759 crossref_primary_10_1016_j_oraloncology_2015_10_009 crossref_primary_10_1016_j_oraloncology_2023_106608 crossref_primary_10_1097_MOO_0000000000000039 crossref_primary_10_3390_cancers13225763 crossref_primary_10_3390_diagnostics11061105 crossref_primary_10_1007_s11282_020_00440_3 crossref_primary_10_1016_j_amjoto_2020_102885 crossref_primary_10_21037_ajo_22_20 crossref_primary_10_1016_j_oraloncology_2021_105641 crossref_primary_10_1177_01455613231170705 crossref_primary_10_3390_ijerph18116012 crossref_primary_10_17779_KAOMP_2020_44_3_003 crossref_primary_10_1002_ohn_689 crossref_primary_10_1001_jamaoto_2018_2421 crossref_primary_10_1002_cre2_519 crossref_primary_10_1007_s00520_014_2155_x crossref_primary_10_1016_j_oraloncology_2016_07_004 crossref_primary_10_1002_hed_24320 crossref_primary_10_1177_0300060520934254 crossref_primary_10_1002_jcp_29744 crossref_primary_10_1016_j_humpath_2020_07_018 crossref_primary_10_1111_jop_12308 crossref_primary_10_12968_denu_2018_45_3_197 crossref_primary_10_1111_jop_12306 crossref_primary_10_1007_s00405_016_4219_7 crossref_primary_10_1016_j_jormas_2023_101713 crossref_primary_10_32635_2176_9745_RBC_2022v68n1_1584 crossref_primary_10_1016_j_oraloncology_2020_104661 crossref_primary_10_1089_dna_2019_5109 crossref_primary_10_1016_j_oraloncology_2017_09_005 crossref_primary_10_1016_j_oraloncology_2021_105371 crossref_primary_10_3390_jcm12041704 crossref_primary_10_1111_jop_12373 crossref_primary_10_1007_s00432_015_2061_8 crossref_primary_10_15448_1980_6108_2021_1_41124 crossref_primary_10_1016_j_bbrc_2017_01_170 crossref_primary_10_1016_j_bjorl_2022_07_001 crossref_primary_10_2147_CMAR_S477791 crossref_primary_10_1001_jamanetworkopen_2021_7083 crossref_primary_10_1016_j_jcms_2018_12_005 crossref_primary_10_1111_apm_12507 crossref_primary_10_1111_odi_13583 crossref_primary_10_1016_j_gene_2020_145283 crossref_primary_10_1245_s10434_015_5070_6 crossref_primary_10_1016_j_jcms_2016_06_007 crossref_primary_10_1007_s12285_018_0152_7 crossref_primary_10_1016_j_drup_2018_09_001 crossref_primary_10_3390_curroncol31010011 crossref_primary_10_1002_hed_25355 crossref_primary_10_1002_hed_24829 crossref_primary_10_3389_fgene_2022_947551 crossref_primary_10_3389_fonc_2019_00339 crossref_primary_10_3390_jcm8010033 crossref_primary_10_1049_syb2_12113 crossref_primary_10_1159_000540977 crossref_primary_10_1111_jcmm_17728 crossref_primary_10_1111_odi_13513 crossref_primary_10_1016_j_cden_2017_08_007 crossref_primary_10_1177_0300060519897187 crossref_primary_10_1002_lary_26632 crossref_primary_10_1002_lary_27720 crossref_primary_10_17650_2222_1468_2022_12_3_28_36 crossref_primary_10_3892_mco_2017_1518 crossref_primary_10_1016_j_joms_2019_03_007 crossref_primary_10_1186_s12903_025_05694_z crossref_primary_10_1016_j_joms_2016_07_005 crossref_primary_10_1016_j_bbrc_2024_150421 crossref_primary_10_3390_cancers14153588 crossref_primary_10_1002_hed_24276 crossref_primary_10_1007_s13193_023_01712_0 crossref_primary_10_18632_oncotarget_3768 crossref_primary_10_1186_s12885_018_4136_9 crossref_primary_10_1016_j_jormas_2024_102166 |
Cites_doi | 10.1016/j.oraloncology.2008.05.017 10.1016/j.ijrobp.2010.04.031 10.1093/jnci/91.24.2081 10.1200/JCO.2011.35.7301 10.1002/cncr.11630 10.1002/cncr.22882 10.1002/bjs.4874 10.1111/j.1600-0714.2009.00797.x 10.1016/j.oraloncology.2011.03.024 10.1016/j.oraloncology.2012.02.010 10.1016/j.oraloncology.2006.10.001 10.1002/cncr.25834 10.1002/cncr.24631 10.1016/j.canrad.2012.06.005 10.1186/1471-2407-6-28 10.1200/JCO.2009.27.4498 10.1177/000348941212100606 10.1200/JCO.2010.31.7883 10.3322/caac.20073 10.1001/archotol.134.5.536 10.1002/hed.21886 10.1016/j.oraloncology.2012.09.006 10.3322/caac.20121 10.1002/hed.2880120604 10.1002/cncr.25087 10.1097/COC.0b013e3181f4759c |
ContentType | Journal Article |
Copyright | 2013 American Cancer Society 2015 INIST-CNRS 2013 American Cancer Society. |
Copyright_xml | – notice: 2013 American Cancer Society – notice: 2015 INIST-CNRS – notice: 2013 American Cancer Society. |
CorporateAuthor | The International Consortium for Outcome Research (ICOR) in Head and Neck Cancer International Consortium for Outcome Research (ICOR) in Head and Neck Cancer |
CorporateAuthor_xml | – name: The International Consortium for Outcome Research (ICOR) in Head and Neck Cancer – name: International Consortium for Outcome Research (ICOR) in Head and Neck Cancer |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1002/cncr.28357 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1097-0142 |
EndPage | 4248 |
ExternalDocumentID | 24114787 28032833 10_1002_cncr_28357 CNCR28357 |
Genre | article Research Support, U.S. Gov't, Non-P.H.S Multicenter Study Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -~X .3N .GA .Y3 05W 0R~ 10A 1CY 1L6 1OC 24P 29B 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5VS 66C 6J9 6P2 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 85S 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANLZ AAONW AARRQ AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABHFT ABIJN ABIVO ABJNI ABLJU ABOCM ABPPZ ABPVW ABQWH ABXGK ACAHQ ACCZN ACFBH ACGFO ACGFS ACGOF ACMXC ACNCT ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEIGN AEIMD AENEX AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AGNAY AHBTC AIACR AIAGR AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BAWUL BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM E3Z EBS EJD EMOBN EX3 F00 F01 F04 F5P FD6 FUBAC G-S G.N GNP GODZA GX1 H.X HBH HGLYW HHY HHZ HZ~ IH2 IX1 J0M JPC KBYEO KQQ KZ1 L7B LATKE LAW LC2 LC3 LH4 LITHE LMP LOXES LP6 LP7 LSO LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D Q.N Q11 QB0 QRW R.K ROL RWI RX1 RYL SJN SUPJJ TEORI UDS UHB V2E V8K V9Y W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WIN WJL WOHZO WQJ WRC WVDHM WXI WXSBR XG1 XPP XV2 Z0Y ZGI ZZTAW ~IA ~WT AAYXX AEYWJ AGYGG CITATION .GJ 31~ 3O- AAQOH ACCFJ AEEZP AEQDE AFFNX AGHNM AI. AIWBW AJBDE C1A HF~ H~9 IQODW J5H N4W NEJ OHT RSU VH1 WHG Y6R YQJ ZXP AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c3107-a8c3c58b2e04f410299935fd7be2b72a2cf6b838e20844c23e50533ff4df5e943 |
IEDL.DBID | DR2 |
ISSN | 0008-543X 1097-0142 |
IngestDate | Fri Jul 11 12:07:15 EDT 2025 Mon Jul 21 05:50:51 EDT 2025 Wed Apr 02 07:20:27 EDT 2025 Tue Jul 01 04:09:09 EDT 2025 Thu Apr 24 22:56:29 EDT 2025 Wed Jan 22 16:38:09 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 24 |
Keywords | Human margins Stomatology Malignant tumor Oral squamous cell carcinoma Survival Oral cavity squamous Cancerology Oral cavity disease time trends Cancer International oral cavity survival |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor CC BY 4.0 2013 American Cancer Society. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3107-a8c3c58b2e04f410299935fd7be2b72a2cf6b838e20844c23e50533ff4df5e943 |
Notes | We thank Esther Eshkol for editorial assistance. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.28357 |
PMID | 24114787 |
PQID | 1465175971 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_1465175971 pubmed_primary_24114787 pascalfrancis_primary_28032833 crossref_primary_10_1002_cncr_28357 crossref_citationtrail_10_1002_cncr_28357 wiley_primary_10_1002_cncr_28357_CNCR28357 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 15 December 2013 |
PublicationDateYYYYMMDD | 2013-12-15 |
PublicationDate_xml | – month: 12 year: 2013 text: 15 December 2013 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | Hoboken, NJ |
PublicationPlace_xml | – name: Hoboken, NJ – name: United States |
PublicationTitle | Cancer |
PublicationTitleAlternate | Cancer |
PublicationYear | 2013 |
Publisher | Wiley-Blackwell |
Publisher_xml | – name: Wiley-Blackwell |
References | 2009; 45 2012; 121 1990; 12 2011; 117 2013; 49 2011 2011; 80 2011; 61 2006; 6 2011; 34 2012; 16 2012; 34 2012; 32 2003; 98 2009; 115 2010; 60 2009; 11 2010; 116 2010; 28 2007; 110 2005; 92 2011; 47 2012; 48 2008; 134 2007; 43 1999; 91 2011; 29 2009; 38 e_1_2_7_6_1 e_1_2_7_5_1 e_1_2_7_9_1 e_1_2_7_8_1 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_17_1 e_1_2_7_16_1 e_1_2_7_2_1 e_1_2_7_14_1 e_1_2_7_13_1 e_1_2_7_12_1 e_1_2_7_11_1 e_1_2_7_26_1 e_1_2_7_27_1 e_1_2_7_28_1 e_1_2_7_29_1 Rampino M (e_1_2_7_10_1) 2012; 32 Howlader N (e_1_2_7_4_1) 2011 American Lung Association (e_1_2_7_3_1) 2011 e_1_2_7_30_1 e_1_2_7_25_1 e_1_2_7_31_1 e_1_2_7_24_1 e_1_2_7_23_1 e_1_2_7_22_1 e_1_2_7_21_1 e_1_2_7_20_1 Gil Z (e_1_2_7_15_1) 2009; 11 O'Neill M (e_1_2_7_18_1) 2011; 34 |
References_xml | – year: 2011 – volume: 134 start-page: 536 year: 2008 end-page: 538 article-title: Consensus statement on the classification and terminology of neck dissection publication-title: Arch Otolaryngol Head Neck Surg. – volume: 45 start-page: 394 year: 2009 end-page: 401 article-title: Current concepts in management of oral cancer—surgery publication-title: Oral Oncol. – volume: 110 start-page: 1033 year: 2007 end-page: 1041 article-title: Analysis of prognostic factors in 146 patients with anterior skull base sarcoma: an international collaborative study publication-title: Cancer. – volume: 28 start-page: 2996 year: 2010 end-page: 3001 article-title: Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02 publication-title: J Clin Oncol. – volume: 47 start-page: 522 year: 2011 end-page: 527 article-title: Comparison between free flap and pectoralis major pedicled flap for reconstruction in oral cavity cancer patients—a quality of life analysis publication-title: Oral Oncol. – volume: 116 start-page: 2635 year: 2010 end-page: 2644 article-title: Trends in oropharyngeal and oral cavity cancer incidence of human papillomavirus (HPV)‐related and HPV‐unrelated sites in a multicultural population: the British Columbia experience publication-title: Cancer. – volume: 49 start-page: 255 year: 2013 end-page: 260 article-title: Postoperative intensity‐modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: patterns of failure publication-title: Oral Oncol. – volume: 11 start-page: 296 year: 2009 end-page: 300 article-title: Contemporary management of head and neck cancers publication-title: Isr Med Assoc J. – volume: 92 start-page: 1008 year: 2005 end-page: 1013 article-title: Improvement in survival following surgery for colorectal cancer publication-title: Br J Surg. – volume: 117 start-page: 2917 year: 2011 end-page: 2925 article-title: Nodal yield and survival in oral squamous cancer: defining the standard of care publication-title: Cancer. – volume: 16 start-page: 601 year: 2012 end-page: 603 article-title: Radiotherapy combined with cetuximab for locally advanced head and neck cancer: results and toxicity publication-title: Cancer Radiother. – volume: 115 start-page: 5700 year: 2009 end-page: 5710 article-title: Lymph node density is a significant predictor of outcome in patients with oral cancer publication-title: Cancer. – volume: 48 start-page: 747 year: 2012 end-page: 752 article-title: Intensity‐modulated radiotherapy improves outcomes in postoperative patients with squamous cell carcinoma of the oral cavity publication-title: Oral Oncol. – volume: 80 start-page: 1412 year: 2011 end-page: 1422 article-title: Intensity‐modulated radiotherapy for oral cavity squamous cell carcinoma: patterns of failure and predictors of local control publication-title: Int J Radiat Oncol Biol Phys. – volume: 38 start-page: 657 year: 2009 end-page: 662 article-title: The prognostic significance of histological features in oral squamous cell carcinoma publication-title: J Oral Pathol Med. – volume: 6 start-page: 28 year: 2006 article-title: A meta‐analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck [serial online] publication-title: BMC Cancer. – volume: 32 start-page: 195 year: 2012 end-page: 199 article-title: Efficacy and feasibility of induction chemotherapy and radiotherapy plus cetuximab in head and neck cancer publication-title: Anticancer Res. – volume: 121 start-page: 395 year: 2012 end-page: 401 article-title: Long‐term quality of life in young adults treated for oral cavity squamous cell cancer publication-title: Ann Otol Rhinol Laryngol. – volume: 98 start-page: 1179 year: 2003 end-page: 1187 article-title: Craniofacial surgery for malignant skull base tumors: report of an international collaborative study publication-title: Cancer. – volume: 61 start-page: 212 year: 2011 end-page: 236 article-title: Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths publication-title: CA Cancer J Clin. – volume: 60 start-page: 277 year: 2010 end-page: 300 article-title: Cancer statistics, 2010 publication-title: CA Cancer J Clin. – volume: 29 start-page: 3503 year: 2011 end-page: 3509 article-title: Population‐based study of competing mortality in head and neck cancer publication-title: J Clin Oncol. – volume: 29 start-page: 1488 year: 2011 end-page: 1494 article-title: Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years publication-title: J Clin Oncol. – volume: 34 start-page: 1212 year: 2012 end-page: 1217 article-title: Improvement in survival during the past 4 decades among patients with anterior skull base cancer publication-title: Head Neck. – volume: 43 start-page: 780 year: 2007 end-page: 784 article-title: The clinical significance of the positive surgical margin in oral cancer publication-title: Oral Oncol. – volume: 91 start-page: 2081 year: 1999 end-page: 2086 article-title: Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced‐stage oropharynx carcinoma publication-title: J Natl Cancer Inst. – volume: 34 start-page: 478 year: 2011 end-page: 482 article-title: Posttreatment quality‐of‐life assessment in patients with head and neck cancer treated with intensity‐modulated radiation therapy publication-title: Am J Clin Oncol. – volume: 12 start-page: 470 year: 1990 end-page: 475 article-title: Postoperative radiotherapy for oral cavity cancers: impact of anatomic subsite on treatment outcome publication-title: Head Neck. – ident: e_1_2_7_14_1 doi: 10.1016/j.oraloncology.2008.05.017 – ident: e_1_2_7_26_1 doi: 10.1016/j.ijrobp.2010.04.031 – ident: e_1_2_7_8_1 doi: 10.1093/jnci/91.24.2081 – ident: e_1_2_7_21_1 doi: 10.1200/JCO.2011.35.7301 – ident: e_1_2_7_6_1 doi: 10.1002/cncr.11630 – ident: e_1_2_7_7_1 doi: 10.1002/cncr.22882 – ident: e_1_2_7_31_1 doi: 10.1002/bjs.4874 – ident: e_1_2_7_30_1 doi: 10.1111/j.1600-0714.2009.00797.x – ident: e_1_2_7_17_1 doi: 10.1016/j.oraloncology.2011.03.024 – ident: e_1_2_7_25_1 doi: 10.1016/j.oraloncology.2012.02.010 – ident: e_1_2_7_29_1 doi: 10.1016/j.oraloncology.2006.10.001 – ident: e_1_2_7_23_1 doi: 10.1002/cncr.25834 – volume-title: Trends in Tobacco Use year: 2011 ident: e_1_2_7_3_1 – ident: e_1_2_7_20_1 doi: 10.1002/cncr.24631 – ident: e_1_2_7_11_1 doi: 10.1016/j.canrad.2012.06.005 – ident: e_1_2_7_9_1 doi: 10.1186/1471-2407-6-28 – volume: 32 start-page: 195 year: 2012 ident: e_1_2_7_10_1 article-title: Efficacy and feasibility of induction chemotherapy and radiotherapy plus cetuximab in head and neck cancer publication-title: Anticancer Res. – ident: e_1_2_7_28_1 doi: 10.1200/JCO.2009.27.4498 – ident: e_1_2_7_16_1 doi: 10.1177/000348941212100606 – ident: e_1_2_7_22_1 doi: 10.1200/JCO.2010.31.7883 – ident: e_1_2_7_19_1 doi: 10.3322/caac.20073 – ident: e_1_2_7_13_1 doi: 10.1001/archotol.134.5.536 – ident: e_1_2_7_12_1 doi: 10.1002/hed.21886 – volume-title: SEER Cancer Statistics Review, 1975–2008 year: 2011 ident: e_1_2_7_4_1 – ident: e_1_2_7_24_1 doi: 10.1016/j.oraloncology.2012.09.006 – ident: e_1_2_7_2_1 doi: 10.3322/caac.20121 – volume: 11 start-page: 296 year: 2009 ident: e_1_2_7_15_1 article-title: Contemporary management of head and neck cancers publication-title: Isr Med Assoc J. – ident: e_1_2_7_27_1 doi: 10.1002/hed.2880120604 – ident: e_1_2_7_5_1 doi: 10.1002/cncr.25087 – volume: 34 start-page: 478 year: 2011 ident: e_1_2_7_18_1 article-title: Posttreatment quality‐of‐life assessment in patients with head and neck cancer treated with intensity‐modulated radiation therapy publication-title: Am J Clin Oncol. doi: 10.1097/COC.0b013e3181f4759c |
SSID | ssj0007253 |
Score | 2.4698107 |
Snippet | BACKGROUND
An association between the survival of patients with oral cavity squamous cell carcinoma (OCSCC) and advancements in diagnosis and therapy has not... The survival rate of patients with oral cavity cancer has improved significantly during the past 2 decades despite higher stage disease, and a higher rate of... An association between the survival of patients with oral cavity squamous cell carcinoma (OCSCC) and advancements in diagnosis and therapy has not been... |
SourceID | proquest pubmed pascalfrancis crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 4242 |
SubjectTerms | Adolescent Adult Aged Aged, 80 and over Biological and medical sciences Carcinoma, Squamous Cell - mortality Carcinoma, Squamous Cell - pathology Carcinoma, Squamous Cell - radiotherapy Carcinoma, Squamous Cell - surgery Cooperative Behavior Head and Neck Neoplasms - mortality Head and Neck Neoplasms - pathology Head and Neck Neoplasms - radiotherapy Head and Neck Neoplasms - surgery Humans International Cooperation Longitudinal Studies margins Medical sciences Middle Aged Mouth - diagnostic imaging Mouth - surgery Mouth Neoplasms - mortality Mouth Neoplasms - pathology Mouth Neoplasms - radiotherapy Mouth Neoplasms - surgery Multiple tumors. Solid tumors. Tumors in childhood (general aspects) oral cavity Otorhinolaryngology. Stomatology Outcome Assessment (Health Care) Prognosis Radiography Radionuclide Imaging Radiotherapy, Adjuvant - methods Retrospective Studies squamous Squamous Cell Carcinoma of Head and Neck survival time trends Tumors Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology Young Adult |
Title | Improvement in survival of patients with oral cavity squamous cell carcinoma: An international collaborative study |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcncr.28357 https://www.ncbi.nlm.nih.gov/pubmed/24114787 https://www.proquest.com/docview/1465175971 |
Volume | 119 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LSwMxEB7Egwji-1EfJaIXha3dPLpb8SLFIoIeRKEXWZI0AVG32m09-Oud2d22VkTQ27JM9jGZSb6ZJN8AHIZeibq3OpDd0Acy8jrQvmkwSomtUVpr7imhf33TuLyXVx3VmYGz0VmYgh9inHAjz8jHa3JwbbKTCWmoTW2_RmxhdJScNmsRIrqdcEdFvKSgrMeBkqIz5iblJ5OmU7PRwqvOUDG-qGjxE-ScRrD5FNRegofRxxc7T55qw4Gp2Y9vvI7__btlWCyxKTsvjGkFZly6CnPX5er7GvSLDESeUGSPKcuGOM6gpbKeZyU_a8Yoscvo2D-zmupSsOxtqCm_wGiNAG_28WG9F33KzlP2-DUfyb7Y5LtjOfHtOty3L-5al0FZsyGwCBSjQMdWWBUb7urSS0QvCECF8t3IOG4irrn1DROL2PF6LKXlwik6Dey97HrlmlJswGzaS90WMISSDYFzuOINI3UcGYvDh-liPEqMP5GowNGo7xJbEppTXY3npKBi5gkpMcmVWIGDsexrQePxo1R1ygTGolTCCyXwlfsjm0jQDUlvOnWoQoqgFCKxZhRWYLMwlklriUEnDowVOM67_JcvSFo3rdv8avsvwjswz6lMR8iDUO3C7KA_dHsIlgammjvFJ661EhY |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxEB5BkQoSAloKpEDrqr1QadOsH_GGWxVRpY_kULVSbivbsaWosCnZhAO_vjPebdKgCgluq9V4H-MZ-5ux_Q3AQRqUaAVnEjlKQyJ1MIkJHYtRSuasMsbwQAn9_qDdu5ZnQzWs9-bQWZiKH2KRcCPPiOM1OTglpI-WrKGucNMm0YXpp_CMSnrHiOpyyR6leU1C2coSJcVwwU7Kj5ZtV-ajl7emRNWEqqbFY6BzFcPGSejkdVVptYzchbT35KY5n9mm-_0Hs-N__98beFXDU3Zc2dMGPPHFJqz36wX4tzCtkhAxp8jGBSvnONSgsbJJYDVFa8kot8vo5D9zhkpTsPLn3FCKgdEyAd6c4sMmP8xXdlyw8cOUJHtglr88i9y3W3B98u2q20vqsg2JQ6yoE5M54VRmuW_JIBHAIAYVKoy09dxqbrgLbZuJzPNWJqXjwis6EByCHAXlO1K8g7ViUvgPwBBNtgVO44q3rTSZtg5HEDvCkJRIf7RowJf7zstdzWlOpTW-5xUbM89JiXlUYgP2F7K3FZPHo1I7KzawEKUqXiiBr9y7N4ocPZH0ZgqPKqQgSiEY6-i0Ae8ra1m2lhh34tjYgMPY53_5grw76F7Gq-1_Ed6F572r_kV-cTo4_wgvOFXtSHmSqk-wNpvO_WfETjO7Ez3kDrVvFjE |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Za9wwEB7SFEKh9D62R6rSvrTgja3D0pa-hE2X9MhSQgP7EowkSxCaeLd79KG_vjO2dzdbQqF9M2Zky6MZ6ZuR9Q3A6ywqkUZvE1lmMZE62sTGnsMoxXinrLU8UkL_aJgfnshPIzXagvfLszANP8Qq4UaeUc_X5OCTMu6tSUN95addYgvT1-C6zFNDNn1wvCaP0rzloExNoqQYrchJ-d667cZydHNiZ6iZ2JS0uApzbkLYeg0a3IbTZe-bX0--dxdz1_W__iB2_N_PuwO3WnDK9htrugtboboHO0ft9vt9mDYpiDqjyM4qNlvgRIOmysaRtQStM0aZXUbn_pm3VJiCzX4sLCUYGG0S4M0pPmx8Yd-x_YqdXU5IsktG-TOwmvn2AZwMPnzrHyZt0YbEI1LUiTVeeGUcD6mMEuELIlChYqld4E5zy33MnREm8NRI6bkIio4DxyjLqEJPioewXY2r8BgYYslc4CKueO6kNdp5nD9ciQEpUf5o0YE3y7ErfMtoToU1zouGi5kXpMSiVmIHXq1kJw2Px5VSuxsmsBKlGl4oga98ubSJAv2Q9GargCqkEEohFOvprAOPGmNZt5YYdeLM2IG39ZD_pQdFf9g_rq-e_IvwC9j5ejAovnwcfn4KNziV7Mh4kqlnsD2fLsJzBE5zt1v7x2-ImRTp |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Improvement+in+survival+of+patients+with+oral+cavity+squamous+cell+carcinoma%3A+An+international+collaborative+study&rft.jtitle=Cancer&rft.au=Amit%2C+Moran&rft.au=Yen%2C+Tzu-Chen&rft.au=Liao%2C+Chun-Ta&rft.au=Chaturvedi%2C+Pankaj&rft.date=2013-12-15&rft.issn=1097-0142&rft.eissn=1097-0142&rft.volume=119&rft.issue=24&rft.spage=4242&rft_id=info:doi/10.1002%2Fcncr.28357&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-543X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-543X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-543X&client=summon |